Background: Unicuspid aortic valve (UAV) is a rare disorder, often difficult to distinguish from
| I NTR OD U CTI ON
Unicuspid aortic valve (UAV) is a rare congenital disorder with a prevalence that ranges from 0.02% in the echocardiographic referral population to 4-6% in patients undergoing valve replacement for aortic stenosis. [1] [2] [3] Bicuspid aortic valve (BAV) disease, on the other hand, is the most common congenital cardiac malformation with a prevalence of about 1-2% in the general population. 4 UAV and BAV have similar clinical presentations (aortic stenosis or regurgitation) but the associated pathologies of UAV seem to develop earlier and progress at a faster rate than BAV. 1 Indeed, most case series of patients with UAV describe young individuals with advanced valvular disease presenting for valve replacement. UAV is characterized as having either an eccentric, unicommissural orifice or a pinhole-shaped acommissural opening presenting with severe stenosis at birth. 1, [5] [6] [7] Unicommissural valves have a larger effective orifice area than acommissural valves; however, both have a smaller, rounded free edge compared to a trileaflet aortic valve (TAV). 6, [8] [9] [10] [11] This severely narrowed opening and predilection for accelerated calcification of the aortic valve results in more frequent and earlier onset of aortic stenosis than found in individuals with BAV or TAV. 6, 12, 13 The more severe pathology that correlates with the lower number of cusps suggests that there may be a phenotypic continuum of similar disease spanning from BAV to UAV. 14 Despite this hypothesized continuum, to our knowledge, an echocardiographic and clinical analyses of patients with UAV and BAV have never been performed. Whether they represent a spectrum of the same disease or they are, indeed, different conditions has yet to be determined. Furthermore, the prevalence of aortopathies in the UAV has not yet been thoroughly examined.
We undertook a comprehensive phenotypic and clinical comparison of patients with UAV and BAV enrolled in the national registry of patients with Genetically-related Thoracic Aortic Aneurisms and related cardiac conditions (GenTAC). GenTAC represents a unique opportunity to compare these two populations, as patients were enrolled at different stages of the disease, including those early in the progression. Our hypothesis is that patients with UAV and BAV share valvular and nonvalvular features suggesting a common developmental defect in cusp separation or outflow tract septation and that UAV may represent a phenotypic extreme of the BAV spectrum.
| M ETH OD S
Patients in GenTAC were enrolled at eight nationally recognized centers for the management of aortic diseases related to genetic condi- image analysis protocol has been previously described in detail. 17 In brief, all echocardiograms were analyzed by a single echocardiographer, ). An aortic valve degeneration score for both UAV and BAV was calculated according to criteria described by Michelena et al. 20 Valvular degeneration was evaluated by scoring three separate components including leaflet thickening, mobility and calcification as 0 (normal), 1 (mildly abnormal), 2 (moderately abnormal), or 3 (severely abnormal). The three individual scores were added together to generate a composite degeneration score with a potential maximum score of 9. A comprehensive echocardiographic and clinical comparison of the two phenotypic groups was subsequently performed.
Statistical analyses were performed at the GenTAC datacoordinating center (RTI) using SAS version 9.3 with a two-tailed clinical characteristics of the subjects are described in Table 1 . By study design, UAV and BAV groups were matched in mean age ( Echocardiographic analysis of UAV and BAV groups is shown in Table 2 . There was no difference in aortic dimensions at any prespecified level of the aorta. In both groups, the majority of patients had the classic phenotype of dilated ascending aorta described for BAV, characterized by the ascending aorta being larger than the sinotubular junction (UAV 93.3% vs BAV 81.3%, P 5 .316), which is demonstrated in Figure 1 (right panel). 21 Interestingly, a finding of an ascending aorta being larger than the aortic root (at the sinuses of Valsalva) was seen more frequently in UAV patients than in BAV patients (86.7% vs 50%, P 5 .029).
FIG URE 1 Examples of bicuspid and unicuspid aortic valves (BAV and UAV, respectively) and typical ascending aortic enlargement in these conditions. BAV was defined as having two commissures (arrows) and an oval, "football-like" opening (left panel). UAV was defined as a valve with one (or none) commissure and a rounded, "soccer ball-like" opening (center panel). Both examples are shown from a parasternal short axis view. In both conditions, enlargement of the ascending aorta (classically described for BAV) was frequently found, shown in the right panel from a suprasternal notch view (dilated ascending aorta marked in full line, normal descending in dotted line) Graded on a scale of 0 (normal), 1 (mildly abnormal), 2 (moderately abnormal), and 3 (severely abnormal).
On evaluation of valvular hemodynamics, there was no difference between the two groups with respect to the incidence and severity of aortic regurgitation. However, aortic stenosis was significantly more common in cases of UAV. Patients with UAV were more likely to have moderate or severe aortic stenosis than those with BAV (58.8% vs 17.6%, P 5 .011). Accordingly, UAV patients had significantly greater mean aortic valve gradients than patients with BAV (22.4 vs 10.4 mm Hg, P < .001) and greater peak aortic valve gradients (39.2 vs 18.6 mm Hg, P < .001). In addition to hemodynamic measures, there were significant differences between the two groups with respect to aortic valve degeneration as UAV subjects had significantly greater mean degeneration scores (2.8) than BAV subjects (1.7, P 5 .043). Interestingly, the most notable difference between the two groups was seen in leaflet mobility characteristics as patients with UAV had mild-moderately reduced mobility (mean score 1.6), while BAV patients had only slightly abnormal leaflet mobility (mean score 0.7, P < .001).
To further characterize patients with aortic stenosis and their degree of valvular degeneration, a subset analysis was performed in subjects found to have any degree of aortic stenosis (Table 3) UAV patients with stenosis tended to be younger and have greater mean and peak aortic valve gradients than BAV patients, these differences were not statistically significant. Of note, patients in both groups had aortic stenosis despite having small degeneration scores with minimal calcification and thickening, a reflection of the young age and the restricted leaflet motion. Accordingly, the aortic valves of the UAV group had significantly decreased mobility compared to the BAV group (1.7 vs 0.8, P 5 0.005).
| DI SCUS SION
Prior reports of UAV have included only data from postmortem or postsurgical specimens. 2 This study is unique in that our population precedes significant aortic valve disease progression resulting in either death or surgical intervention to the aortic valve. We performed a comprehensive comparison of UAV and BAV patients that were age, gender, and BSA matched within the GenTAC Registry, to understand how similar (or dissimilar) these pathologies are. To our knowledge, this is the first study It is interesting that the aortic dimensions, family history, and prior aortic surgeries were similar between the two groups. Furthermore, the majority of patients in both groups exhibited the typical pattern of dilated ascending aorta for BAV, postulated to be related to sheer stress on the ascending aorta due to turbulent flow through a narrowed aortic valve orifice. 21, 22 Intriguingly, the ascending aorta was larger than the aortic root more commonly in UAV than in BAV, perhaps reflective of a more severe phenotypic pattern of the aortopathy or the hemodynamic consequences of more severe aortic stenosis. Patients from both populations had similar rates of aortic coarctation necessitating repair along with rates of surgical intervention at all prespecified levels of the aorta.
Similar to the pattern seen in BAV, UAV was also more common in males than females. 12, 14 Of note, a family history of BAV or of aortic aneurysm/dissection or coarctation was equally common in UAV and BAV individuals, suggesting a common, likely genetic, familial predisposition to these two forms of aortic valve pathology. Larger series of BAV patients have described a heritable pattern of BAV, and the data from the present study suggest that there is a common inheritance pattern in UAV patients. 23 Given the lack of leaflet thickening and calcification, the degree of stenosis found in BAV and UAV is mostly due to differences in the cusp morphology impeding appropriate valve opening.
The combination of these findings suggests that there is a common link in the inheritance patterns of patients with UAV and those with BAV.
To the extent that UAV and BAV share a common underlying predisposition, UAV appears to represent a more severe phenotype as patients with UAV tend to have earlier onset and faster progression of aortic stenosis, consistent with prior studies evaluating pathologic specimens of surgically excised aortic valves. 1,2 Patients with UAV had smaller indexed aortic valve areas along with greater mean and peak aortic valve gradients than the BAV cohort, likely due to both the leaflet morphology as well as calcific progression. When analyzing the subset of patients from both groups diagnosed with aortic stenosis, UAV subjects had more severe aortic stenosis than BAV patients. Additionally, they tended to be younger than those with a BAV, although this was not statistically significant, possibly as a result of the relatively small sample size.
The mechanism for this pattern of aggressive aortic stenosis appears to be related mostly to leaflet mobility. Overall, patients with UAV had significant reduction of leaflet mobility whereas patients in the BAV cohort had only slightly reduced leaflet mobility, even when that patients with a more aggressively stenotic UAV manifest with early aortic involvement that is associated with an increased incidence of ascending dilatation, dissection and rupture. 1, 12, 26 Owing to the earlier presentation and increased likelihood of more severe stenosis, UAV typically requires surgical treatment at least one to two decades earlier than BAV. 8 Furthermore, with increasing patient age, differentiation between UAV and BAV can be challenging as focal calcification of UAV can mimic the appearance of the raphe seen in BAV on echocardiography. 6, 11 If cardiac imaging cannot distinguish between UAV and BAV, then application of current BAV guidelines to these patients is an appropriate course of action with close monitoring for complications of both the aortic valve and aorta.
While our study has novel and interesting findings, some limitations must be acknowledged. The number of patients in the GenTAC Registry with UAV was small, albeit larger than for any previous study. We were able to take advantage of the large number of subjects with BAV in the GenTAC cohort to identify a control group that was matched by the most significant demographic characteristics, therefore allowing a meaningful comparison of BAV and UAV patients. Unfortunately, the small number of cases also prevents a proper comparison of genetic variants, the ultimate method to prove the proposed linkage between BAV and UAV. Furthermore, the study likely did not capture UAV patients that required procedures early in life, particularly individuals with acommissural aortic valves as they tend to have an aggressive clinical course.
Moving forward, it would be valuable to investigate the progression of both BAV and UAV over time as the present study lacks long term longitudinal monitoring of disease progression and development.
Although UAV and BAV have distinctly different morphologies, the findings of this study suggest that they represent a continuum of the same disease. Patients with UAV represent a more aggressive phenotype in the spectrum of BAV syndromes, presenting with more severe aortic stenosis at a younger age compared to BAV. Adoption of current recommendations for the management and monitoring of BAV to patients with UAV is a reasonable consideration, with the understanding that both aortic stenosis and aortic complications occur earlier in patients with UAV.
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